570. Evidente VG, Premkumar AP, Adler CH, Caviness JN, Driver-Dunckley E, Lyons MK. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease. Acta Neurol Scand. 2011;124(3):211-214
571. Rodriguez-Oroz MC, Obeso JA, Lang AE et al. . Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005;128(10):2240- 2249
572. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56(4):548-551
573. Odekerken VJ, van Laar T, Staal MJ et al. . Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37-44
574. Weaver FM, Follett KA, Stern M et al. . Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012;79(1):55-65.
575. Krause M, Fogel W, Heck A et al. . Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry. 2001;70(4):464-470.
576. Volkmann J, Albanese A, Kulisevsky J et al. . Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord. 2009;24(8):1154-1161.
577. Zhang J, Li J, Chen F, Liu X, Jiang C, Hu X, Ma L, Xu Z. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: A meta-analysis of randomized controlled trials. Clin Neurol Neurosurg. 2021 Feb;201:106450. doi: 10.1016/j.clineuro.2020.106450. Epub 2020 Dec 31. PMID: 33421741.
578. Wang JW, Zhang YQ, Zhang XH, Wang YP, Li JP, Li YJ. Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta- Analysis of Randomized Controlled Trials. PLoS One. 2016 Jun 1;11(6):e0156721. doi: 10.1371/journal.pone.0156721. PMID: 27248139; PMCID: PMC4889151.
579. Peng L, Fu J, Ming Y, Zeng S, He H, Chen L. The long-term efficacy of STN vs GPi deep brain stimulation for Parkinson disease: A meta-analysis. Medicine (Baltimore). 2018 Aug;97(35):e12153. doi: 10.1097/MD.0000000000012153. PMID: 30170458; PMCID: PMC6393030.
580. Parihar R, Alterman R, Papavassiliou E, Tarsy D, Shih LC. Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor. Tremor Other Hyperkinet Mov (N Y). 2015;5:321. Published 2015 Jul 6. doi:10.7916/D81V5D35
581. Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry. 1999;66(3):289-296. doi:10.1136/jnnp.66.3.289
582. Charles, P. D., Van Blercom, N., Krack, P., Lee, S. L., Xie, J., Besson, G., et al. (2002). Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 59, 932–934. doi: 10.1212/wnl.59.6.932
583. Kim HY, Chang WS, Kang DW, Sohn YH, Lee MS, Chang JW. Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease. J Korean Neurosurg Soc. 2013;54(2):118-124. doi:10.3340/jkns.2013.54.2.118
584. Welter, M. L., Houeto, J. L., Tezenas du Montcel, S., Mesnage, V., Bonnet, A. M., Pillon, B., et al. (2002). Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain 125, 575–583. doi: 10.1093/brain/awf050
585. Piboolnurak, P., Lang, A. E., Lozano, A. M., Miyasaki, J. M., Saint-Cyr, J. A., Poon, Y.-Y. W., et al. (2007). Levodopa response in long-term bilateral subthalamic stimulation for Parkinson’s disease. Mov. Disord. 22, 990–997. doi: 10.1002/mds.2148
586. Zaidel, A., Bergman, H., Ritov, Y., and Israel, Z. (2010). Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov. Disord. 25, 2379–2386. doi: 10.1002/mds.23294
587. Lin Z, Zhang X, Wang L, Zhang Y, Zhou H, Sun Q, Sun B, Huang P, Li D. Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson's Disease. Front Hum Neurosci. 2021 Feb 4;15:604433. doi: 10.3389/fnhum.2021.604433. PMID: 33613209; PMCID: PMC7889513.
588. Kleiner-Fisman, G.; Herzog, J.; Fisman, D.N.; Tamma, F.; Lyons, K.E.; Pahwa, R.; Lang, A.E.; Deuschl, G. Subthalamic nucleus deep brain stimulation: Summary and meta- analysis of outcomes. Mov. Disord. 2006, 21 (Suppl. S14), S290–S304
589. Defer GL, Widner H, Marié RM, Rémy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD). 1999;14:572–584 Mov Disord
590. Bronstein, J.M.; Tagliati, M.; Alterman, R.L.; Lozano, A.M.; Volkmann, J.; Stefani, A.; Horak, F.B.; Okun, M.S.; Foote, K.D.; Krack, P.; et al. Deep brain stimulation for Parkinson disease: An expert consensus and review of key issues. Arch. Neurol. 2011, 68, 165
591. Artusi CA, Lopiano L, Morgante F. Deep Brain Stimulation Selection Criteria for Parkinson's Disease: Time to Go beyond CAPSIT-PD. J Clin Med. 2020 Dec 4;9(12):3931. doi: 10.3390/jcm9123931. PMID: 33291579; PMCID: PMC7761824.
592. Saranza G, Lang AE. Levodopa challenge test: indications, protocol, and guide. J Neurol. 2020 Apr 24. doi: 10.1007/s00415-020-09810-7. Epub ahead of print. PMID: 32333167
593. Fabbri M, Coelho M, Guedes LC et al (2017) Response of nonmotor symptoms to levodopa in late-stage Parkinson’s disease: results of a levodopa challenge test. Parkinsonism Relat Disord 39:37–43
594. Feng T, Li W, Lu L, Wang Y, Shi W, Zhang J, Wang Y, Chan P. Acute stepwise challenge test with levodopa in treated patients with parkinsonism. Parkinsonism Relat Disord. 2009 Jun;15(5):354-8. doi: 10.1016/j.parkreldis.2008.08.010. Epub 2008 Nov 14. PMID: 19010079.
595. Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158. PMID: 23406026.